Functional diversity increases the efficacy of phage combinations. (2021)

First Author: Wright RCT
Attributed to:  Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1099/mic.0.001110

PubMed Identifier: 34850676

Publication URI: http://europepmc.org/abstract/MED/34850676

Type: Journal Article/Review

Volume: 167

Parent Publication: Microbiology (Reading, England)

Issue: 12

ISSN: 1350-0872